| 摘要 |
The present invention relates to the use of the triglycoside (22R, 25R)-spiro-5-en3beta-yl-alpha-L-rhamnopyranosyl-(1->2gal)-O-p-D-glucop yranosyl-(1->3gal)-beta-D-galactopyranose for the preparation of pharmaceutical compositions for treating skin tumors. |
